| C1q | complement component 1q |
| GSH | reduced glutathione |
| HD | Huntington’s disease |
| IP | intraperitoneal |
| IV | intravenous |
| MCAO | middle cerebral artery occlusion |
| NF-κB | nuclear factor kappa light-chain enhancer of activated B cells |
| NOS (eNOS, iNOS and nNOS) | nitric oxide synthase (endotelial, inducible and neuronal isoforms) |
| NPA | 3-nitropropionic acid |
| ROS | reactive oxygen species |
| TTC | 2,3,5-triphenyltetrazolium chloride |
| TUNEL | terminal deoxyribonucleotidyl transferase-mediated dUTP-fluorescein nick-end labeling |